Freespira
Freespira is the only FDA-cleared digital therapeutic proven to significantly reduce or eliminate anxiety/panic attacks and PTSD symptoms by training users to normalize respiratory irregularities.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD140—210m (Dealroom.co estimates Apr 2024.)
Kirkland Washington (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$1.2m | Seed | ||
$1.6m | Debt | ||
| N/A | $3.9m | Early VC | |
* | N/A | $1.6m | Early VC |
| N/A | $3.5m | Early VC | |
$10.0m | Late VC | ||
* | N/A | $22.6m | Late VC |
| Total Funding | AUD66.2m | ||